nanomedicine

Malignant tumor is still one of the most critical diseases in clinic. Current therapeutic strategies include surgery, chemoradiotherapy, targeted therapy, and immunotherapy. Nevertheless, the development of novel drugs with superior efficacy and reduced drug toxicity remains a goal for researchers. The rise of nanomedicine has injected new momentum into oncology treatment. Among nano-platforms, m…

FAU researchers develop revolutionary technology: Funding needed for the final step toward practical application

Introduction: The Next Frontier of Lipid Nanoparticles (LNPs) in Cancer Nanomedicine For decades, cancer nanomedicine has pursued a central goal — to deliver potent therapies directly to tumors while sparing healthy tissues. Lipid nanoparticles (LNPs) have emerged as one of the most clinically validated nanocarriers, from mRNA delivery to small-molecule encapsulation. Yet, a new generation of lip…

Artzi’s promotion and Feng’s appointment strengthen the Institute’s efforts in nanomedicine and immunoengineering, as well as modeling of chronic kidney diseases

The 17th International Nanomedicine and Drug Delivery Symposium (NanoDDS’19) will be held on the MIT campus September 22-24, 2019. We anticipate accommodating >400 participants from around the world. This symposium will particularly focus on translation medicine, and will be featuring speakers from both biotech industry and academia.   Co-Chairs Daniel Anderson Associate Professor, Chemical Engin…

Biomaterials Science web writer, Robert van Lith, highlights a HOT article from the journal